Vizient recently published a paper on the impact of oncology drug shortages for patients and provider members. Drs. Carina Dolan and Jeni Hayes share their insights of the causes and how to improve things moving forward with host Gretchen Brummel.  

Guest speakers: 

Jeni Hayes, PharmD, MSPharm, BCPS 

Show Notes: 

[00:48-01:52] Drugs included in shortage of cancer drugs report

[01:53-02:58] How we define drug shortages

[02:59-04:03] Specific event that precipitated the oncology drug shortage

[04:04- 05:39] Overall impact on the sales for these medications

[05:40-07:25] What demand are we seeing for these medications

[07:26-08:23] How Vizient Pharmacy Program participants have been affected

[08:24-09:59] Looking at the shortage severity and its impact on Vizient Pharmacy Program participants

[10:06-12:13] How we improve things moving forward

[12:14-13:49] What front line pharmacy staff should know about these shortages

Links | Resources: 

Evaluating the impact of the oncology drug shortage white paper

Evaluating the impact of the oncology drug shortage fact sheet

Vizient: Lack of Information Across Supply Chain Exacerbating Oncology Drug Shortage press release

Webinar: Oncology insights: new therapies and drug shortages

Drug shortage: Oncology agents mitigation strategy

Subscribe Today!

Apple Podcasts

Amazon Podcasts

Google Podcasts

Spotify

Android

RSS Feed